Increasing public and private life science research and development expenditure, progressing drug discovery and clinical diagnostics field, and rising government spending on pharmaceutical R&D in emerging nations are the key factors driving the growth of life science and chemical market and offering new growth opportunities for the market players. It is expected for the market to reach $48.84 billion by 2019.
Emerging markets including China, India, Singapore, and Brazil have become attractive destinations for companies engaged in the development and distribution of life science. A number of factors such as rising R&D activities by big pharma and biotech companies, increased government investments to develop pharmaceutical industry, and growing number of CROs in developing nations are offering new growth avenues for players active in the life science market.
Crysdot will be a key player engaged in the development and distribution of life science, adopting new product development and launching as key business strategy to ensure the growth in the global life science market.